Primary Identifier | MGI:97747 | Organism | mouse, laboratory |
Chromosome | 6 | NCBI Gene Number | 19016 |
Mgi Type | protein coding gene |
description | FUNCTION: Automated description from the Alliance of Genome Resources (Release 8.0.0) Enables several functions, including DNA-binding transcription factor activity, RNA polymerase II-specific; RNA polymerase II transcription regulatory region sequence-specific DNA binding activity; and arachidonate binding activity. Involved in several processes, including cellular response to platelet-derived growth factor stimulus; nuclear receptor-mediated signaling pathway; and regulation of transcription by RNA polymerase II. Acts upstream of or within with a negative effect on wound healing involved in inflammatory response. Acts upstream of or within several processes, including brown fat cell differentiation; cellular response to lithium ion; and regulation of gene expression. Located in cytosol and nucleus. Part of SUMO ligase complex. Is expressed in several structures, including adipose tissue; alimentary system; genitourinary system; musculoskeletal system; and nervous system. Used to study abdominal obesity-metabolic syndrome; congenital generalized lipodystrophy type 2; familial partial lipodystrophy; primary pulmonary hypertension; and systemic lupus erythematosus. Human ortholog(s) of this gene implicated in several diseases, including cardiovascular system disease (multiple); end stage renal disease; lipodystrophy (multiple); obesity; and type 2 diabetes mellitus. Orthologous to human PPARG (peroxisome proliferator activated receptor gamma). PHENOTYPE: Homozygotes for targeted null mutations exhibit lethality due to placental defects. Heterozygotes show greater B cell proliferation, enhanced leptin secretion, and resistance to diet-induced adipocyte hypertrophy and insulin resistance. [provided by MGI curators] |